Robert Gross

faculty photo
Associate Professor of Medicine
Attending Physician, Infectious Diseases, Hospital of the University of Pennsylvania
Attending Physician, Infectious Diseases, Philadelphia Veterans Administration Medical Center
Member, Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine
Senior Fellow, Leonard Davis Institute, University of Pennsylvania, Perelman School of Medicine
Co-Director, Clinical Core, Center for AIDS Research (CFAR), University of Pennsylvania, Perelman School of Medicine
Co-Director, Clinical Core, Penn Mental Health in AIDS Research Center
Associate Fellow, Center for Public Health Initiatives, University of Pennsylvania, Perelman School of Medicine
Co-Director, Center for AIDS Research (CFAR), University of Pennsylvania, Perelman School of Medicine
Department: Medicine

Contact information
804 Blockley Hall
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, Perelman School of Medicine
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215-898-2437
Fax: 215-573-5315
Education:
B.A. (Italian)
Cornell University , 1986.
M.D.
Cornell University, 1991.
M.S.C.E. (Pharmacoepidemiology)
University of Pennsylvania, 2000.
Permanent link
 

Description of Research Expertise

HIV clinical epidemiology; outcomes of HIV treatment; adherence to therapy including development of methods to measure adherence

Description of Itmat Expertise

Dr. Gross focuses on antiretroviral therapy for HIV with a primary focus on the relation between adherence to therapy and outcome and barriers to adherence and interventions to overcome barriers to adherence. He also conducts research on new antiretroviral agents as well as pharmacoepidemiology and pharmacogenetics of HIV drugs.

Selected Publications

Mosepele M, Mokgatlhe L, Hudson FP, Letsatsi V, Gross R: Cholesterol Screening and Statin Prescription is Low Among HIV-infected Patients on Protease-Inhibitor Regimens in Botswana. The Open AIDS Journal 2017 (in press).

Crits-Christoph P, Gallop R, Noll E, Rothbard A, Diehl CK, Connolly Gibbons MB! Gross R, Rhodes KV.: HIV+ Medicaid Patients with Medical and Behavioral Health Comorbidities: Impact of a Medical Home Model on Health Care Utilization and Costs. American Journal of Managed Care 2017 (in press).

Lo Re III V, Roy J, Tate J, Carbonari D, Kostman J, Goetz M, Gross R, Hennessy S.: Risk of Liver Decompensation with Cumulative Use of Mitochondrial Toxic Nucleoside Analogues in HIV/Hepatitis C Virus Coinfection. Pharmacoepidemiology and Drug Safety 2017 (in press).

Vujkovic M, Bellamy SL, Zuppa AF, Gastonguay M, Moorthy GS, Ratshaa B, Han X, Steenhoff AP, Mosepele M, Strom BL, Aplenc R, Bisson GP, Gross R.: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-treated HIV Patients in Botswana. JAIDS 2017 (in press).

Coppock D, Zambo D, Moyo Dumisani, Tanthuma G, Chapman J, Lo Re III V, Graziani A,Lowenthal E, Hanrahan N, Littman-Quinn R, Kovarik C, Albarracin D, Holmes J, Gross R.: Development and Usability of a Smartphone Application for Tracking Antiretroviral Medication Refill Data for Human Immunodeficiency Virus Methods of Information in Medicine 2017 (in press).

Harrison JD, Dochney JA, Blazekovic S, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Siegel S, Schnoll RA, Ashare RL. : The Nature and Consequences of Cognitive Deficits among Tobacco Smokers with HIV: A Comparison to Tobacco Smokers without HIV. Journal of Neurovirology 2017 (in press).

Gross R, Bellamy SL, Ratshaa B, Han X, Vujkovic M, Aplenc R, Steenhoff AP, Mosepele M, Moorthy G, Zuppa AF, Strom BL, Bisson GP : CYP2B6 Genotypes and Early Efavirenz-based HIV Treatment Outcomes in Botswana. AIDS 2017 (in press).

Ioannides KL, Chapman J, Marukutira T, Tshume O, Anabwani G, Gross R, Lowenthal ED : Patterns of HIV Treatment Adherence do not Differ Between Male and Female Adolescents in Botswana. AIDS Behav 21(2): 410-414, Feb 2017.

Ravimohan S, Tamula N, Nfanyana K, Ni H, Steenhoff AP, Gross R, Weissman D, Bisson GP: Elevated pre-ART CD39+CD8+ T-cell frequency is associated with early mortality in advanced HIV/TB. Clin Infect Dis Page: 155, Feb 2017.

Brier MJ, Chambless DL, Gross R, Chen J, Mao JJ: Perceived Barriers to Treatment Predict Breast Cancer Survivors’ Adherence to Aromatase Inhibitors. Cancer 123(1): 169-176, Jan 2017.

back to top
Last updated: 09/25/2017
The Trustees of the University of Pennsylvania